logo

For the Inventor, By the Inventor

Penzberg, Germany

Thomas Von Hirschheydt

This inventor holds 12 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2004-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Von Hirschheydt. Retrieved from https://idiyas.com/inventor/thomas-von-hirschheydt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 16.7

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:

goldMedal12 out of 5,026 
 
Hoffmann-La Roche Inc.
 patents

Years Active: 2004-2024

Loading Chart...
12 patents (USPTO):Explore Patents
1. 11945839 - Depletion of light chain mispaired antibody variants by hydrophobic interaction chromatography (2024-04-02),
2. 8058283 - 7H-pyrido[3,4-D]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors (2011-11-15),
3. 7939532 - Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents (2011-05-10),
4. 7879884 - Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents (2011-02-01),
5. 7625896 - Pyridylsulfonamide derivatives (2009-12-01),
6. 7429605 - Phenylpyridine derivatives (2008-09-30),
7. 7288557 - Triazole derivatives (2007-10-30),
8. 7208506 - Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents (2007-04-24),
9. 7169781 - Imidazole derivatives and their use as pharmaceutical agents (2007-01-30),
10. 7144889 - Triarylimidazoles (2006-12-05),
11. 6946471 - 2-(2,6-Dichlorophenyl)-Diarylimidazoles (2005-09-20),
12. 6790852 - 2-(2,6-dichlorophenyl)-diarylimidazoles (2004-09-14),

Title: Thomas Von Hirschheydt: Innovator in Biopharmaceuticals

Introduction

Thomas Von Hirschheydt is a prominent inventor based in Penzberg, Germany. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative methods for antibody separation and protein kinase inhibitors. With a total of 12 patents to his name, his work continues to impact the medical and pharmaceutical industries.

Latest Patents

Among his latest patents is a method for the depletion of light chain mispaired antibody variants by hydrophobic interaction chromatography. This invention focuses on separating multispecific CrossMab antibodies from their mispaired variants, enhancing the efficacy of bispecific antibodies in therapeutic applications. Another notable patent involves 7H-pyrido[3,4-D]pyrimidin-8-ones, which are designed as protein kinase inhibitors. This invention aims to provide new compounds for the treatment and prevention of illnesses such as cancer.

Career Highlights

Thomas Von Hirschheydt has built a successful career at Hoffmann-La Roche Inc., where he has been instrumental in advancing biopharmaceutical research. His innovative approaches have led to breakthroughs in antibody technology and cancer treatment, solidifying his reputation as a leading inventor in the field.

Collaborations

Throughout his career, Thomas has collaborated with esteemed colleagues, including Edgar Voss and Ulrike Reiff. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of cutting-edge technologies.

Conclusion

Thomas Von Hirschheydt's contributions to biopharmaceuticals through his innovative patents and collaborations highlight his role as a key figure in the industry. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…